… the magnitude … comparing dual bronchodilator therapy versus LABA monotherapy. The
mean difference in FEV 1 improvement from baseline to 12 weeks for dual bronchodilator therapy …

… The bronchodilator response to isoproterenol declined in magnitude and duration during
the study period. Although the data were not statistically significant, graphic presentation of the …

… therapy was associated with the greatest positive effect on outcomes in patients with COPD.
Of the bronchodilator … with respect to both direction and magnitude. Use of MTC meta- …

… comparing LABA plus LAMA and LABA/ICS combination, improvements in lung function
achieved with two bronchodilators … this test, and reversibility of this magnitude is not unusual in …

… treatment effects and treatment comparisons. LS mean differences … -naïve patients, but the
magnitude of effect of SGRQ total … intervention with dual bronchodilator therapy, as opposed to …

… The one appa¬ ratus used in these studies delivered bronchodilator to the patient via IPPB.
With a simple alteration it functioned as a powered nebulizer with the same pressure and …

… In this context, bronchodilators are unlikely to modify the magnitude of stimulation of … isotime
CWR comparisons of ⩒ E /⩒CO 2 following active drug and placebo. Such comparisons are …

… on the cell surface will change the magnitude and duration of response. These changes can
be clinically relevant as they may limit the therapeutic response to treatment with prolonged …

… Pre- and postbronchodilator comparisons were made using … magnitude seen in the present
study group with advanced emphysema is clinically beneficial. Changes of this magnitude …

… by evaluating bronchodilator reversibility by the magnitude of … In a comparison of the
bronchodilator response to albuterol … mL improvement following bronchodilator indicates …